Skip to main content
Skip to content
Case File
efta-01499701DOJ Data Set 10Other

EFTA01499701

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01499701
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
SOUTHERN FINANCIAL LLC ACCT. For the Period 9/1/B to 9/30/13 Note •• Unrealized Gairt Loss is shown as WA" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan team for additional information. Equity Detail Price OuaMiy Value Adjusted Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 18.40 16,535.000 304,244.00 290,997.40 13,248.60 ASCENA RETAIL GROUP INC COM 04351G-10-1 ASNA 19.93 70,500.000 1,405,065.00 N/A - N/A BIOGEN IDEC INC 09062X-103 BIIB 240.76 2,095.000 504,392.20 250,454.95 253,937.25 FACEBOOK INC-A 30303M-10-2 FB 50.23 17,500.000 879,025.00 665,000.00 214,025.00 GENERAL ELECTRIC CO 369604-10-3 GE 23.89 23,000.000 549,470.00 496,109.08 53,360.92 17,480.00 3.18% JP MORGAN CHASE & CO 46825H-10-0 JPM 51.69 21,753.000 1,124,412.57 N/A" N/A 33,064.56 2.94% JPM VALUE ADVANTAGE FD - Ran FUND 1400 4812A2-58-7 JVAI X 25.83 78,709.170 2,017,316.03 2,000,000.00 17,316.03 19,992.12 0.99% Total US Large Cap Equity 58.783,924.80 33,702,581.43 3651,885.80 870,638.88 1.04% J.P Morgan A000unt 'age 'a , Consolidated Statement Page 43 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00023496 SDNY_GM_00292694 EFTA01499701

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.